Main > ONCOLOGY (**) > Leukemia>ProMyelocytic>Acute>R*** > Treatment > Co: IL. T. Arsenic Trioxide Inj.

---

Co: IL. T. Arsenic Trioxide Inj.'s subsections
(*) USA Approval Date: ?
>from Retinoid & Anthracycline CT
>Presence t(15;17) Translocation>
Company
Patent>Assignee, Claims, No., Etc
Patent>Total USA No.: 4
Patent>UpDate: 2007. 01.02
Patent>US Expiration Year: 2018
TradeMark
TradeMark Web-Site

Co: IL. T. Arsenic Trioxide Inj.'s products
This section has no products